NKTR-102 (Etirinotecan Pegol)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for NKTR-102 (Etirinotecan Pegol), covering 2016-12-22 to 2016-12-22. Get the full timeline:
Most recent: Clinical Trial Update: A Study in Cancer Patients to Evaluate the Effect of a Single Dose of NKTR-102 (Etirinotecan Pegol) on the QTc Interval and to Assess Pharmacokinetics and Safety [Phase 1]